News
-
-
PRESS RELEASE
Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline
Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline. Acquisition includes Phase III clinical development of MDM2 inhibitor navtemadlin for myelofibrosis patients -
PRESS RELEASE
Ipsen finalise l'acquisition de Kartos Therapeutics, renforçant son portefeuille d'oncologie en phase avancée
Ipsen finalise l'acquisition de Kartos Therapeutics, renforçant son portefeuille d'oncologie en phase avancée. Navtemadlin, inhibiteur de MDM2 en phase III dans la myélofibrose -
-
-
PRESS RELEASE
5.096 Million Units Exported in Six Months: Beyond the Headline Figure, China is Reshaping Global Automotive Rules
China's auto exports reach record high in first half of 2026 driven by BYD and Chery. Chery maintains top position as passenger car exporter for 23 years, influencing global automotive standards -
-
-
-